Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

2.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

3.

Distinct results for patients with positive and negative pancreatic cancer who are treated with systemic therapy, chemotherapy, and radiation.

4.

Artificial intelligence is assisting in the earlier detection and treatment of breast cancer.

5.

Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot